Literature DB >> 28214595

Impact of Delayed Infusion Time in Umbilical Cord Blood Transplantation.

Richard Mitchell1, John E Wagner2, Claudio Brunstein3, Qing Cao4, David H McKenna5, Michael R Verneris6.   

Abstract

In umbilical cord blood (UCB) transplantation, UCB units are typically thawed, washed, and infused into the patient as rapidly as possible. In some instances there is a delay in the time from the unit thaw and wash procedure to infusion into the patient. Therefore, we examined the effect of thaw duration time on engraftment outcomes in 567 patients undergoing UCB transplantation. With a range of 32 to 523 minutes, a prolonged thaw duration had no obvious effect on the incidence of neutrophil engraftment or time to recovery. This was true for recipients of single UCB transplantation (incidence: 97% versus 93%, P = .13; time to neutrophil recovery: 21 days versus 21 days, P = .32; and platelet recovery: 79% versus 78%, P = .48), and similar results were observed in double UCB transplantation (time to neutrophil engraftment: 20 days versus 19 days, P = .71). However, there was a trend toward better platelet recovery in recipients of double UCB transplants with prolonged thaw duration (HR, 1.28; P = .06). In conclusion, this study demonstrates prolonged thaw duration has no detrimental effect on engraftment after single or double UCB transplantation.
Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cord blood; Engraftment; Thaw time

Mesh:

Year:  2017        PMID: 28214595      PMCID: PMC5438205          DOI: 10.1016/j.bbmt.2017.02.010

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  16 in total

Review 1.  Patient care during infusion of hematopoietic progenitor cells.

Authors:  Annette Sauer-Heilborn; Diane Kadidlo; Jeffrey McCullough
Journal:  Transfusion       Date:  2004-06       Impact factor: 3.157

2.  Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation.

Authors:  R L Haspel; G Kao; B Y Yeap; C Cutler; R J Soiffer; E P Alyea; V T Ho; J Koreth; B R Dey; S L McAfee; E C Attar; T Spitzer; J H Antin; K K Ballen
Journal:  Bone Marrow Transplant       Date:  2007-11-26       Impact factor: 5.483

3.  Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.

Authors:  Duncan Purtill; Katherine Smith; Sean Devlin; Richard Meagher; Joann Tonon; Marissa Lubin; Doris M Ponce; Sergio Giralt; Nancy A Kernan; Andromachi Scaradavou; Cladd E Stevens; Juliet N Barker
Journal:  Blood       Date:  2014-09-02       Impact factor: 22.113

4.  Impact of long-term cryopreservation on single umbilical cord blood transplantation outcomes.

Authors:  Richard Mitchell; John E Wagner; Claudio G Brunstein; Qing Cao; David H McKenna; Troy C Lund; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-28       Impact factor: 5.742

5.  Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.

Authors:  Claudio G Brunstein; Jonathan A Gutman; Daniel J Weisdorf; Ann E Woolfrey; Todd E Defor; Theodore A Gooley; Michael R Verneris; Frederick R Appelbaum; John E Wagner; Colleen Delaney
Journal:  Blood       Date:  2010-08-04       Impact factor: 22.113

6.  Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies.

Authors:  Juliet N Barker; Andromachi Scaradavou; Cladd E Stevens
Journal:  Blood       Date:  2009-12-22       Impact factor: 22.113

7.  Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts.

Authors:  Sharon Avery; Weiji Shi; Marissa Lubin; Anne Marie Gonzales; Glenn Heller; Hugo Castro-Malaspina; Sergio Giralt; Nancy A Kernan; Andromachi Scaradavou; Juliet N Barker
Journal:  Blood       Date:  2010-12-13       Impact factor: 22.113

8.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

Authors:  P Rubinstein; L Dobrila; R E Rosenfield; J W Adamson; G Migliaccio; A R Migliaccio; P E Taylor; C E Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

9.  Outcomes among 562 recipients of placental-blood transplants from unrelated donors.

Authors:  P Rubinstein; C Carrier; A Scaradavou; J Kurtzberg; J Adamson; A R Migliaccio; R L Berkowitz; M Cabbad; N L Dobrila; P E Taylor; R E Rosenfield; C E Stevens
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

10.  Mislabeled units of umbilical cord blood detected by a quality assurance program at the transplantation center.

Authors:  Jeffrey McCullough; David McKenna; Diane Kadidlo; David Maurer; Harriett J Noreen; Kathy French; Claudio Brunstein; John E Wagner
Journal:  Blood       Date:  2009-06-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.